
Elev8 Center of New Jersey
Newark, New Jersey

Family Service Bureau of Newark
Newark, New Jersey

POWER House
Newark, New Jersey
No centers match
Try a different search term
3 SAMHSA-listed treatment centers in Newark, New Jersey. Free, confidential help available 24/7 — most callers reach a licensed counselor in under 60 seconds.

Newark, New Jersey

Newark, New Jersey

Newark, New Jersey
Try a different search term
Newark, New Jersey has 3 SAMHSA-verified addiction treatment centers offering a range of evidence-based programs. Substance use disorders affect millions of Americans, and access to quality, evidence-based treatment is critical to recovery.
Available programs in Newark include 2 residential/inpatient rehab programs, 1 outpatient program, 2 dual diagnosis (co-occurring mental health) programs, and 1 medical detox facility. All listed facilities are sourced directly from the federal SAMHSA National Registry of Substance Abuse Treatment Services.
Most treatment centers in Newark accept Medicaid, Medicare, and major private insurance plans including Aetna, Cigna, BlueCross BlueShield, and UnitedHealthcare. Under the Affordable Care Act (ACA) and the Mental Health Parity Act, insurance providers are required to cover substance use disorder treatment at the same level as other medical conditions. Call (319) 271-2077 for a free insurance verification — no obligation, completely confidential.
When selecting from the 3 treatment options in Newark, consider: the type and severity of the substance use disorder, whether co-occurring mental health conditions require dual diagnosis treatment, your insurance coverage and financial situation, the distance from home and your support network, and the facility's accreditation and evidence-based approach. Our helpline is available 24/7 at (319) 271-2077 to help match you with the right program — free and confidential.
Free, confidential assistance matching you with the right program in Newark.
Treatment centers in Newark accept most major insurance plans including Medicaid, Medicare, Blue Cross Blue Shield, Aetna, Cigna, and UnitedHealthcare. Many facilities also offer sliding scale fees and payment plans. Call (319) 271-2077 to verify your coverage before admission.
The addiction-treatment landscape in Newark, New Jersey, reflects the broader epidemiology of substance use in the region: alcohol use disorder remains the most prevalent diagnosis at treatment intake nationally, opioid use disorder presents the highest overdose mortality, stimulant use disorder is increasingly common (cocaine and methamphetamine), and polysubstance use is the rule rather than the exception. Newark providers structure programs to address this diversity — most treat the full range of substance-use disorders within an integrated clinical framework rather than maintaining substance-specific tracks.
Personality disorders — particularly borderline personality disorder and antisocial personality disorder — are common in addiction-treatment populations and shape both treatment course and outcome. Newark programs increasingly incorporate Dialectical Behavior Therapy (DBT) skills training, mentalization-based therapy, and structured approaches to interpersonal-effectiveness building. Treatment for personality-disorder patterns typically requires longer treatment episodes than substance-only presentations and ongoing therapy well beyond the formal program completion.
Medicaid coverage for addiction treatment in Newark depends on New Jersey's Medicaid program structure, expansion status, and any 1115 waivers in effect. The federal IMD Exclusion historically limited Medicaid coverage of large residential facilities; many states have obtained 1115 waivers expanding this coverage. Patients with Medicaid in New Jersey should contact their managed-care plan or the state Medicaid office to identify in-network addiction-treatment providers — many residential facilities accept Medicaid even when their primary patient mix is commercial.
Most Newark patients enter treatment at one of three levels: medically managed detox (if withdrawal risk warrants medical supervision), residential treatment (24-hour structured environment for those without stable recovery support at home), or intensive outpatient (9+ hours/week of programming for those able to maintain work/school and recover at home with structured support). The choice depends on ASAM criteria assessment performed by licensed clinicians, not solely on patient preference or insurance coverage limitations.
Overdose response in Newark: signs of opioid overdose include slowed or stopped breathing, blue lips or fingertips, pinpoint pupils, unconsciousness, and limp body. If you suspect overdose, call 911 immediately, administer naloxone (Narcan nasal spray is most common), perform rescue breathing or CPR if trained, and stay with the person until paramedics arrive. New Jersey Good Samaritan laws generally protect callers from prosecution for drug-related offenses when seeking emergency help, with specific protections varying by state.
Aftercare for Newark patients begins planning during the initial treatment episode, not at discharge. Standard components include: a named outpatient provider with a scheduled first appointment within 7 days, medication continuation plans (MAT, psychiatric medications, medical comorbidities), a sober-housing recommendation if returning home presents relapse risk, introduction to mutual-support communities matched to patient preference (AA, NA, SMART Recovery, Refuge Recovery, LifeRing), and a relapse-prevention plan with named triggers, named coping skills, and named support contacts.
The intake process at most Newark residential programs begins with a comprehensive clinical assessment covering substance-use history (substance, quantity, duration, last use, withdrawal history), mental-health history, physical-health status (including medications and chronic conditions), social context (housing, employment, family, legal), and recovery history (prior treatment episodes, what worked, what didn't). The assessment typically takes 60-90 minutes and produces an initial treatment plan within 72 hours.